Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 4, 2025
Real-World Outcomes of First-Line Systematic Treatment in Locally Advanced or Metastatic Upper Urinary Tract Urothelial Carcinoma With Renal Impairment (YUSHIMA Study)Tomoki Kimura, Motohiro Fujiwara, Yuya Maezawa, et al.
Internal Medicine (Tokyo, Japan)|March 22, 2022
False-positive Elevation of Beta-D-glucan and Aspergillus Galactomannan Levels Due to Mendelson's Syndrome after Rice AspirationTasuku Yamamoto, Keiji Oishi, Junki Suizu, et al.
Respiratory Medicine Case Reports|February 16, 2022
Antineutrophil cytoplasmic antibody-negative granulomatosis with polyangiitis localized to the lungsYuichi Ohteru, Kazuki Hamada, Keiji Oishi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 22, 2025
Clinical Features and Risk Factors of Enfortumab Vedotin-Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study (YUSHIMA Study)Takahiko Soma, Hajime Tanaka, Yuki Nakamura, et al.
Japanese Journal of Clinical Oncology|January 28, 2026
Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysisShugo Yajima, Soichiro Yoshida, Wei Chen, et al.
Journal of Clinical Medicine|August 28, 2020
A Novel Role of Growth Differentiation Factor (GDF)-15 in Overlap with Sedentary Lifestyle and Cognitive Risk in COPDTsunahiko Hirano, Keiko Doi, Kazuto Matsunaga, et al.
The Prostate|March 19, 2026
Real-World Comparison of Triplet Versus Doublet Therapy in Japanese Patients With High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Propensity-Weighted Analysis From the YUSHIMA Registry and Exploratory Bayesian Evidence SynthesisYosuke Yasuda, Soichiro Yoshida, Shugo Yajima, et al.
BMJ Open|March 25, 2025
Add-on or switch to vibegron in patients with overactive bladder insufficiently responding to initial 4-week antimuscarinics: a randomised, parallel-group, multicentre trial (<b>ADVISR</b>) <b>protocol</b>Takanobu Yamamoto, Soichiro Yoshida, Yuya Maezawa, et al.
NPJ Primary Care Respiratory Medicine|January 28, 2022
The 1-minute sit-to-stand test to detect desaturation during 6-minute walk test in interstitial lung diseaseKeiji Oishi, Kazuto Matsunaga, Maki Asami-Noyama, et al.
BMC Urology|March 6, 2023
A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)Soichiro Yoshida, Taro Takahara, Yuki Arita, et al.
Pageof 6